Yoshiki Kusunoki

11PUBLICATIONS
27CO-AUTHORS
Traditional Chinese medicine and treatmentsDisease surveillanceInformation visualisationEpigenetics (incl. genome methylation and epigenomics)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 26, 2025
Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD).

Yuta Nakamura, Ichiro Horie, Hiroshi Yano

|Jun 16, 2025
Continuous glucose monitoring-derived time in range is associated with changes in cognitive function test scores in Japanese patients with type 2 diabetes mellitus.

Maki Inoue, Yoshiki Kusunoki, Mana Ohigashi

|May 07, 2024
Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial.

Ryotaro Bouchi, Kazuo Izumi, Naoki Ishizuka

|Jan 22, 2024
Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open-label, prospective study.

Yuta Nakamura, Ichiro Horie, Tadahiro Kitamura

|Jan 17, 2024
Association between brain imaging biomarkers and continuous glucose monitoring-derived glycemic control indices in Japanese patients with type 2 diabetes mellitus.

Chikako Inoue, Yoshiki Kusunoki, Mana Ohigashi

|Dec 11, 2023
Association between low-carbohydrate diets and continuous glucose monitoring-derived time in ranges.

Keiko Osugi, Yoshiki Kusunoki, Mana Ohigashi

Pageof 2

Frequent Collaborators

3 joint publications

Mana Ohigashi

2 joint publications

Hidenori Koyama

2 joint publications

Yuta Nakamura

2 joint publications

Ichiro Horie